Market Tracker

06/24 5:16pm ET

AMAG Pharmaceuticals Inc (NASDAQ:AMAG)

23.42
Delayed Data
As of Jun 24
 -1.47 / -5.91%
Today’s Change
17.92
Today|||52-Week Range
77.73
-22.42%
Year-to-Date
Why AMAG Pharmaceuticals, Inc. Plunged 19.2% in May
Jun 12 / MotleyFool.com - Paid Partner Content
 

Today’s Trading

Previous close24.89
Today’s open23.74
Day’s range23.21 - 24.66
Volume1,620,366
Average volume (3 months)1,211,019
Market cap$809.8M
Dividend yield--
Data as of 4:00pm ET, 06/24/2016

Growth & Valuation

Earnings growth (last year)-82.73%
Earnings growth (this year)+465.09%
Earnings growth (next 5 years)-1.75%
Revenue growth (last year)+236.28%
P/E ratio65.3
Price/Sales2.55
Price/Book0.87

Competitors

 Today’s
change
Today’s
% change
VIVOMeridian Bioscience ...-0.57-2.98%
GHDXGenomic Health Inc-0.48-1.81%
NTRANatera Inc-0.15-1.10%
ALRPRBAlere Inc0.000.00%
Data as of 4:00pm ET, 06/24/2016

Financials

Next reporting dateJuly 21, 2016
EPS forecast (this quarter)$1.22
Annual revenue (last year)$418.3M
Annual profit (last year)$32.8M
Net profit margin7.84%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Executive Director
William K. Heiden
President &
Chief Operating Officer
Frank E. Thomas
Corporate headquarters
Waltham, Massachusetts

Forecasts